| Identifier |
20100308_nanos_sciplatform_05_ppt.pdf |
| Title |
Low-Contrast Letter Acuity Detects Visual Function Improvement in Phase 3 Relapsing MS Trials of Natalizumab |
| Creator |
Laura J. Balcer; Steven L. Galetta; Chris Polman; Richard Rudick; Frederick Munschauer; Peter Calabresi; Eric R. Eggenberger; Annie Zhang; Richard Kim |
| Affiliation |
(LJB) (SLG) University of Pennsylvania School of Medicine, Philadelphia, PA; (CP) VU Medical Center, Amsterdam, Netherlands; (RR) Cleveland Clinic Foundation, Cleveland, OH; (FM) Buffalo General Hospital, Buffalo, NY; (PC) Johns Hopkins University School of Medicine, Baltimore, MD; (EE) Michigan State Univerisity, East Lansing, MI; (AZ) (RK) Biogen Idec, Cambridge, MA |
| Subject |
Multiple Sclerosis (MS); Visual Function; Low-contrast Letter Acuity; Natalizumab |
| Description |
In the AFFIRM trial, natalizumab reduced sustained visual loss by low-contrast letter acuity (LCA), but not highcontrast visual acuity (HCA). Natalizumab was associated with improvements in disability and quality of life; we determined whether similar improvements could be demonstrated for vision. |
| Date |
2010-03-08 |
| Language |
eng |
| Format |
application/pdf |
| Format Creation |
Microsoft PowerPoint |
| Type |
Text |
| Source |
2010 North American Neuro-Ophthalmology Society Annual Meeting |
| Relation is Part of |
NANOS 2010: Scientific Platform Presentations |
| Collection |
Neuro-Ophthalmology Virtual Education Library: NANOS Annual Meeting Collection: https://novel.utah.edu/collection/nanos-annual-meeting-collection/ |
| Publisher |
North American Neuro-Ophthalmology Society |
| Holding Institution |
Spencer S. Eccles Health Sciences Library, University of Utah |
| Rights Management |
Copyright 2010. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright |
| ARK |
ark:/87278/s6d53tcz |
| Setname |
ehsl_novel_nam |
| ID |
181303 |
| Reference URL |
https://collections.lib.utah.edu/ark:/87278/s6d53tcz |
